Company registration number 10030535 (England and Wales)
PENTA THERAPEUTICS LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2026
PENTA THERAPEUTICS LIMITED
BALANCE SHEET
AS AT 28 FEBRUARY 2026
28 February 2026
- 1 -
2026
2025
£
£
£
£
Current assets
16,525
15,231
Creditors: amounts falling due within one year
(4,315)
(4,838)
Net current assets
12,210
10,393
Net assets
12,210
10,393
Capital and reserves
12,210
10,393
Notes to the financial statements
1
Employees

The average number of persons, including directors, employed by the company during the year was as follows:

2026
2025
Number
Number
Employees
0
0

For the year ended 28 February 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for:

(a) ensuring that the Company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) preparing financial statements which give a true and fair view of the state of affairs of the Company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the Company.

 

The financial statements have been prepared in accordance with the micro-entity provisions.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

PENTA THERAPEUTICS LIMITED
BALANCE SHEET (CONTINUED)
AS AT 28 FEBRUARY 2026
28 February 2026
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 22 October 2026 and are signed on its behalf by:
Mr DW Gilroy
Director
Company registration number 10030535 (England and Wales)
2026-02-282025-03-01falsefalseCCH SoftwareCCH Accounts Production 2026.100No description of principal activityMs Patricia De SouzaDW Gilroy Consulting Limitedfalse100305352025-03-012026-02-28100305352026-02-28100305352025-02-2810030535core:CurrentFinancialInstrumentscore:WithinOneYear2026-02-2810030535core:CurrentFinancialInstrumentscore:WithinOneYear2025-02-28100305352024-02-292025-02-2810030535bus:Director22025-03-012026-02-2810030535bus:PrivateLimitedCompanyLtd2025-03-012026-02-2810030535bus:SmallCompaniesRegimeForAccounts2025-03-012026-02-2810030535bus:Micro-entities2025-03-012026-02-2810030535bus:AuditExemptWithAccountantsReport2025-03-012026-02-2810030535bus:Director12025-03-012026-02-2810030535bus:FullAccounts2025-03-012026-02-28xbrli:purexbrli:sharesiso4217:GBP